Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Social work researchers create easier, accurate way to analyze TSCC trauma results

  • Alzheimer's culprit causes memory loss even before brain degeneration

  • Blood Pressure Medications Can Lead to Increased Risk of Stroke

  • Pembrolizumab shows real promise against head and neck cancer, study suggests

  • A patient's budding cortex -- in a dish? Networking neurons thrive in 3-D human 'organoid'

  • People with multiple sclerosis may have double the risk of dying early

  • Migraine surgery for teens: Good results in initial experience

  • Study shows how students understand mathematics

  • Parents feel racial socialization may help minority children succeed in school

  • Brain training induces lasting brain, mental health gains for veterans, civilians with brain injury

  •